glucosamine has been researched along with tacrolimus in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Giannoukakis, N; Harnaha, J; Lakomy, R; Lu, L; Ma, L; Machen, J; Qian, S; Robbins, PD; Rudert, WA; Trucco, M; Wright, M | 1 |
| Cheong, KA; Kim, CH; Lee, AY; Park, CD | 1 |
3 other study(ies) available for glucosamine and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Immunosuppressive effects of glucosamine.
Topics: Adenosine Triphosphate; Animals; beta-Galactosidase; Cyclosporine; Dendritic Cells; DNA-Binding Proteins; Dose-Response Relationship, Drug; Flow Cytometry; Glucosamine; Humans; Immunosuppressive Agents; Jurkat Cells; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; NFATC Transcription Factors; Nuclear Proteins; Tacrolimus; Time Factors; Transcription Factors; Transplantation Tolerance | 2002 |
Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Topics: Animals; CD3 Complex; Chemokine CCL11; Chemokine CCL17; Chemokines; Cytokines; Dermatitis, Atopic; Dermatophagoides farinae; Disease Models, Animal; Drug Therapy, Combination; Eosinophils; Glucosamine; Immunoglobulin E; Immunosuppressive Agents; Interleukin-13; Interleukin-5; Male; Mast Cells; Mice; Scavenger Receptors, Class B; Skin; Tacrolimus; Th2 Cells | 2012 |